3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Multiple Myeloma
20
Lymphoma, Non-Hodgkin
20
Leukemia, Myeloid, Acute
11
Hodgkin Disease
8
Precursor Cell Lymphoblastic Leukemia-Lymphoma
7
Myelodysplastic Syndromes
6
Leukemia, Lymphocytic, Chronic, B-Cell
6
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
5
Lymphoma, Mantle-Cell
3
Lymphoma, Follicular
3
Gliosarcoma
3
Glioblastoma
3
Sezary Syndrome
2
Mycosis Fungoides
2
Lymphoma, T-Cell, Cutaneous
2
Lymphoma, Large-Cell, Immunoblastic
2
Lymphoma, Large B-Cell, Diffuse
2
Lymphoma, B-Cell, Marginal Zone
2
Lymphoma
2
Leukemia, Hairy Cell
2
Leukemia
2
Hematologic Neoplasms
2
Glioma
2
Burkitt Lymphoma
2
Warts
1
Waldenstrom Macroglobulinemia
1
Sarcoma, Myeloid
1
Recurrence
1
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
1
Pinealoma
1
Interventions
Imatinib Mesylate
6
Cytarabine
5
ponatinib
4
nilotinib
4
venetoclax
3
fludarabine phosphate
3
Mycophenolic Acid
3
thymoglobulin
2
fludarabine
2
enasidenib
2
Methotrexate
2
Lenalidomide
2
Cyclosporine
2
Cyclophosphamide
2
Azacitidine
2
Antilymphocyte Serum
2
quizartinib
1
methanesulfonic acid
1
glasdegib
1
etoposide phosphate
1
daratumumab
1
bosutinib
1
asciminib
1
Whole-Body Irradiation
1
Transplantation
1
Temozolomide
1
Tacrolimus
1
Stem Cell Transplantation
1
Standard of Care
1
RFT5-SMPT-dgA immunotoxin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Leukemia, Myeloid
×
plerixafor
×
Clear all
No trials found.